These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10597874)

  • 1. Correlates of hormone replacement therapy use in Italian women, 1992-1996.
    Chiaffarino F; Parazzini F; La Vecchia C; Bianchi MM; Benzi G; Ricci E; Chiantera V
    Maturitas; 1999 Oct; 33(2):107-15. PubMed ID: 10597874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-sectional study of determinants of menopausal age and hormone replacement therapy use in Italian women.
    Amigoni S; Morelli P; Chatenoud L; Parazzini F
    Climacteric; 2000 Mar; 3(1):25-32. PubMed ID: 11910606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. General and medical factors associated with hormone replacement therapy among women attending menopause clinics in Italy.
    Progetto Menopausa Italia Study Group
    Menopause; 2001; 8(4):290-5. PubMed ID: 11449088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlates of oral contraceptive use in Italian women, 1991-93.
    Parazzini F; Negri E; Ricci E; Franceschi S; La Vecchia C
    Contraception; 1996 Aug; 54(2):101-6. PubMed ID: 8842587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sociodemographic and clinical factors associated with HRT use in women attending menopause clinics in Italy.
    Pansini F; Bacchi Modena AB; de Aloysio D; Gambacciani M; Meschia M; Parazzini F; Sciacchitano G; di Micco R; Peruzzi E; Maiocchi G;
    Climacteric; 2000 Dec; 3(4):241-7. PubMed ID: 11910583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends of determinants of hormone therapy use in Italian women attending menopause clinics, 1997-2003.
    Parazzini F;
    Menopause; 2008; 15(1):164-70. PubMed ID: 17581495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
    Oddens BJ; Boulet MJ
    Obstet Gynecol; 1997 Aug; 90(2):269-77. PubMed ID: 9241307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Life prevalence and determinants of hormone replacement therapy in women living in Porto, Portugal.
    Lucas R; Barros H
    Maturitas; 2007 Jul; 57(3):226-32. PubMed ID: 17293067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of first prescription of hormone replacement therapy. A follow-up study among 1689 women aged 45-60 years.
    Groeneveld FP; Bareman FP; Barentsen R; Dokter HJ; Drogendijk AC; Hoes AW
    Maturitas; 1994 Dec; 20(2-3):81-9. PubMed ID: 7715478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
    Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
    Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of hormone replacement therapy in Italian women aged 50-70 years.
    Manzoli L; Di Giovanni P; Del Duca L; De Aloysio D; Festi D; Capodicasa S; Monastra G; Romano F; Staniscia T
    Maturitas; 2004 Nov; 49(3):241-51. PubMed ID: 15488353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of hormone replacement therapy by menopausal women in six family-practice teaching clinics in Israel.
    Vinker S; Kaplan B; Yaphe J; Cohen O; Shumla V; Shapira G; Shofty I; Kitai E
    Climacteric; 2003 Mar; 6(1):75-80. PubMed ID: 12725667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of estrogen replacement therapy use in northern Italy.
    Parazzini F; La Vecchia C; Negri E; Bianchi C; Fedele L
    Rev Epidemiol Sante Publique; 1993; 41(1):53-8. PubMed ID: 8465065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personal use of HRT by postmenopausal women doctors and doctors' wives in the north of Italy.
    Biglia N; Cozzarella M; Ponzone R; Marenco D; Maggiorotto F; Fuso L; Sismondi P
    Gynecol Endocrinol; 2004 Mar; 18(3):165-74. PubMed ID: 15255286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Climacteric symptoms and knowledge about hormone replacement therapy among Hong Kong Chinese women aged 40-60 years.
    Lam PM; Leung TN; Haines C; Chung TK
    Maturitas; 2003 Jun; 45(2):99-107. PubMed ID: 12787968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of hormone replacement therapy by menopausal women: a comparison between primary care patients and the general population.
    Nakhlé AR; Galobardes B; Humair JP; Stalder H
    Soz Praventivmed; 2005; 50(4):238-44. PubMed ID: 16167508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal patterns and correlates of hormone replacement therapy use in middle-aged women.
    Johannes CB; Crawford SL; Posner JG; McKinlay SM
    Am J Epidemiol; 1994 Sep; 140(5):439-52. PubMed ID: 8067336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy and risk of colon and rectal cancer.
    Fernandez E; La Vecchia C; Braga C; Talamini R; Negri E; Parazzini F; Franceschi S
    Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):329-33. PubMed ID: 9568789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and characteristics associated with use of hormone replacement therapy in Britain.
    Moorhead T; Hannaford P; Warskyj M
    Br J Obstet Gynaecol; 1997 Mar; 104(3):290-7. PubMed ID: 9091004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.